| News

Hemex attracts Swiss investors

11.02.2021

A group of experienced Swiss entrepreneurs and private investors have participated in a significantly oversubscribed financing round for Hemex. The biotech incubator will use the funds to accelerate its global expansion.

Hemex, a Basel Area-based venture capitalist and incubator for biotech startups, has reported raising “a substantial amount” in an oversubscribed Series C financing round. According to a press release, the capital contribution was raised exclusively from a group of Swiss private investors.

Now, Hemex plans to use this money to hire “world-class talent” and accelerate its global expansion. The company wants to “invest in carefully selected startups” and deliver on its promise of “changing the future of healthcare”.

“We anticipate another year of strong growth for healthcare, both domestically and on a global level,” said Hemex CEO Pascal Winnen in the press release. “This vote of confidence for our business model from a group of successful entrepreneurs confirms that Hemex is on the right track for substantial future success.”

Hemex’s partners include the investment and innovation promotion agency Basel Area Business & Innovation and its DayOne Accelerator. Its portfolio includes Opterion Health AG, which announced at the end of January that it would be moving from the canton of Obwalden to the co-working space The 5th Floor in Muttenz. Basel Area Business & Innovation is providing support for the relocation.

In addition, Hemex has invested in Scailyte, a company based at the Novartis Campus of the Switzerland Innovation Park Basel Area. Support has also been provided to Resistell based in Muttenz, which claims to have made the world’s fastest antibiogram, and Basel cancer diagnostics expert Artidis.

Share this article

Sign up to receive our newsletter in your inbox.

You may also be interested in

TÜV NORD CERT opens office in Basel
Basel Area Business & Innovation, Invest

TÜV NORD CERT opens office in Basel

The certification specialist TÜV NORD CERT has opened its own office in Basel. From here, customers across the whole of...

Read More
Marija Plodinec: “I like a good challenge”
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

Marija Plodinec: “I like a good challenge”

As a CEO of a medtech startup looking for funding, you need to do two things extremely well: make sure...

Read More
Typewise presents new smartphone keyboard
Basel Area Business & Innovation, Innovation, Invest

Typewise presents new smartphone keyboard

The startup Typewise is presenting the third generation of its virtual keyboard for smartphones. Typewise 3.0 uses a new patented...

Read More
Basel Area starts new i4Challenge
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basel Area starts new i4Challenge

The next round of the i4Challenge support program is getting underway. With this, Basel Area Business & Innovation is striving...

Read More
Basel Area shapes future health innovations
Basel Area Business & Innovation, Innovation, Invest, Switzerland Innovation Park

Basel Area shapes future health innovations

A success factor for the Basel Area has been its steady transformation. From chemicals through the pharmaceutical industry to the...

Read More
Biggest successes in 2020 for biotechs in the Basel Area
Basel Area Business & Innovation, Innovation, Invest

Biggest successes in 2020 for biotechs in the Basel Area

Biotech companies in the Basel Area played a key role in the sector’s record performance in 2020. The latest Swiss...

Read More
1 2 3 43

Do you have a question? We'd like to hear from you.